RNVA: AI 评分 57/100 — AI 分析 (4月 2026)

Rennova Health, Inc. operates healthcare facilities in the United States. The company focuses on providing services through its hospitals and clinics, primarily in Tennessee and Kentucky.

Key Facts: AI Score: 57/100 Sector: Healthcare

公司概况

概要：

Rennova Health, Inc. operates healthcare facilities in the United States. The company focuses on providing services through its hospitals and clinics, primarily in Tennessee and Kentucky.

Rennova Health, Inc. provides healthcare services through its hospitals and clinics, primarily operating in Tennessee and Kentucky. With a focus on acute care and rural healthcare access, the company faces challenges in a competitive landscape while striving to maintain patient care standards and navigate the evolving healthcare regulatory environment.

RNVA是做什么的？

Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida. The company operates in the healthcare services sector, primarily focusing on providing medical services through its subsidiaries. As of December 31, 2021, Rennova Health owns and operates one operating hospital in Oneida, Tennessee, an acute care hospital and a physician's practice in Jamestown, Tennessee, and a rural clinic in Williamsburg, Kentucky. These facilities offer a range of medical services to their respective communities. The company's operations are concentrated in providing healthcare access in rural areas, addressing the needs of underserved populations. Rennova Health aims to deliver quality patient care while navigating the complexities of the healthcare industry. The company's business model involves managing and operating healthcare facilities, providing medical services, and generating revenue through patient care and related services. Rennova Health faces competition from other healthcare providers and must adhere to regulatory requirements and industry standards to maintain its operations and market position.

RNVA的投资论点是什么？

Rennova Health, Inc. presents a challenging investment case given its current financial metrics. The company's negative P/E ratio of -0.42 and a profit margin of -41.4% indicate significant profitability issues. While the gross margin of 59.5% suggests potential in its core operations, the company needs to address its cost structure and revenue generation. Key growth catalysts include expanding services within its existing facilities and potentially acquiring additional healthcare facilities. However, potential risks include regulatory compliance, competition, and the company's ability to achieve sustainable profitability. Investors should closely monitor Rennova Health's financial performance and strategic initiatives to assess its long-term viability.

RNVA在哪个行业运营？

Rennova Health operates within the healthcare services industry, which is characterized by increasing demand for medical services, technological advancements, and evolving regulatory landscapes. The industry is highly competitive, with numerous players ranging from large hospital chains to smaller clinics and specialized healthcare providers. Rennova Health's focus on rural healthcare positions it within a niche market, but it also faces challenges related to access to resources and skilled personnel. The company's success depends on its ability to adapt to industry trends, maintain regulatory compliance, and deliver quality patient care in a cost-effective manner.

Medical - Diagnostics & Research

Healthcare

RNVA有哪些增长机遇？

Expanding Services in Existing Facilities: Rennova Health can grow by expanding the range of medical services offered at its existing hospitals and clinics. This includes adding specialized treatments, diagnostic capabilities, and rehabilitation programs. The market for specialized healthcare services is growing, driven by an aging population and increasing prevalence of chronic diseases. By investing in new technologies and attracting skilled medical professionals, Rennova Health can attract more patients and increase revenue. Timeline: Ongoing.
Acquiring Additional Healthcare Facilities: Rennova Health can pursue growth through strategic acquisitions of additional hospitals, clinics, or physician practices. This would allow the company to expand its geographic reach and increase its patient base. The market for healthcare acquisitions is active, with opportunities to acquire distressed or underperforming assets. By carefully evaluating potential acquisitions and integrating them effectively, Rennova Health can achieve economies of scale and improve its overall financial performance. Timeline: Ongoing.
Improving Operational Efficiency: Rennova Health can improve its profitability by focusing on operational efficiency. This includes streamlining administrative processes, reducing costs, and optimizing resource utilization. The market for healthcare efficiency solutions is growing, driven by the need to control costs and improve patient outcomes. By implementing lean management principles and investing in technology, Rennova Health can reduce waste, improve productivity, and enhance its competitive position. Timeline: Ongoing.
Telehealth Services Expansion: Rennova Health can leverage telehealth to extend its reach and provide convenient access to healthcare services. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing consumer demand. By offering virtual consultations, remote monitoring, and online prescription refills, Rennova Health can attract new patients and improve patient satisfaction. This expansion can be particularly beneficial in rural areas where access to specialists may be limited. Timeline: Ongoing.
Partnerships with Local Healthcare Providers: Rennova Health can form strategic partnerships with other healthcare providers in its region to expand its network and offer a wider range of services. This includes collaborating with specialists, hospitals, and rehabilitation centers to provide coordinated care to patients. The market for healthcare partnerships is growing, driven by the need to improve patient outcomes and reduce costs. By building strong relationships with local providers, Rennova Health can enhance its reputation and attract more patients. Timeline: Ongoing.

Market capitalization of $0.00B indicates a small-cap company with potential for high volatility.
Negative P/E ratio of -0.42 reflects current unprofitability.
Profit margin of -41.4% highlights significant challenges in achieving profitability.
Gross margin of 59.5% suggests potential in core operations if costs are managed effectively.
Beta of -0.05 indicates low correlation with the overall market, potentially offering some downside protection.

RNVA提供哪些产品和服务？

Operates one hospital in Oneida, Tennessee.
Manages an acute care hospital in Jamestown, Tennessee.
Oversees a physician's practice in Jamestown, Tennessee.
Runs a rural clinic in Williamsburg, Kentucky.
Provides healthcare services to local communities.
Focuses on acute care and general medical services.

RNVA如何赚钱？

Generates revenue through patient care services.
Operates hospitals and clinics in rural areas.
Provides acute care and general medical services.
Manages physician practices.

Residents of Oneida, Tennessee.
Residents of Jamestown, Tennessee.
Residents of Williamsburg, Kentucky.
Patients seeking acute care services.
Individuals requiring general medical care.

Local presence in rural communities.
Established healthcare facilities.
Relationships with local physicians.
Focus on underserved populations.

什么因素可能推动RNVA股价上涨？

Ongoing: Efforts to improve operational efficiency and reduce costs.
Ongoing: Expansion of services within existing healthcare facilities.
Ongoing: Potential acquisitions of additional healthcare facilities.
Upcoming: Implementation of telehealth services to expand reach.
Upcoming: Strategic partnerships with local healthcare providers.

RNVA的主要风险是什么？

Potential: Regulatory compliance challenges and changes in healthcare policies.
Potential: Competition from larger healthcare providers and hospital systems.
Potential: Economic downturn affecting patient volumes and revenue.
Ongoing: Negative P/E ratio and low profit margin indicating financial instability.
Ongoing: Limited liquidity and potential price volatility due to OTC trading.

RNVA的核心优势是什么？

Local presence in rural markets.
Established healthcare facilities.
Focus on underserved populations.
Gross margin of 59.5%.

RNVA的劣势是什么？

Negative P/E ratio of -0.42.
Profit margin of -41.4%.
Limited geographic reach.
Small market capitalization.

RNVA有哪些机遇？

Expanding services in existing facilities.
Acquiring additional healthcare facilities.
Improving operational efficiency.
Telehealth services expansion.

RNVA面临哪些威胁？

Regulatory compliance challenges.
Competition from larger healthcare providers.
Economic downturn affecting patient volumes.
Changes in healthcare reimbursement policies.

RNVA的竞争对手是谁？

Aveo Capital Corp — Financial services and investment company. — (AVCRF)
CBS Corp — Media conglomerate, different industry. — (CBSC)
ICBU Corp — Diversified holding company. — (ICBU)
Interpace Biosciences Inc — Molecular diagnostics company. — (IDXG)
LIFD Inc — Technology company focused on digital solutions. — (LIFD)

Key Metrics

MoonshotScore: 57/100

Company Profile

CEO: Seamus Lagan
Headquarters: West Palm Beach, US
Employees: 96
Founded: 1995

AI Insight

AI analysis pending for RNVA

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Rennova Health, Inc. do?

Rennova Health, Inc. operates healthcare facilities, including hospitals and clinics, primarily in Tennessee and Kentucky. The company focuses on providing acute care and general medical services to local communities. Rennova Health aims to address the healthcare needs of underserved populations in rural areas by offering a range of medical services through its facilities. The company's business model involves managing and operating these healthcare facilities, generating revenue through patient care, and navigating the complexities of the healthcare industry.

What do analysts say about RNVA stock?

AI analysis is currently pending for RNVA stock, and there is no available analyst consensus. Given the company's financial metrics, including a negative P/E ratio and low profit margin, investors should conduct thorough due diligence and carefully assess the company's growth prospects and risk factors. Key valuation metrics to consider include revenue growth, gross margin, and operational efficiency. Investors should also monitor the company's strategic initiatives and regulatory compliance efforts.

What are the main risks for RNVA?

Rennova Health faces several key risks, including regulatory compliance challenges, competition from larger healthcare providers, and economic downturns affecting patient volumes. The company's financial instability, as indicated by its negative P/E ratio and low profit margin, also poses a significant risk. Additionally, trading on the OTC market exposes the company to limited liquidity and potential price volatility. Investors should carefully consider these risks and conduct thorough due diligence before investing in RNVA.